Press release
08.07.2022 To the attention of interested persons Medicines containing nomegestrol or chlormadinone: PRAC recommends new measures to minimise risk of […]
Important notification
04.07.2022 To the attention of laboratories in the field of in vitro diagnostics in Romania and all interested parties Please […]
Press release
10.06.2022 To the attention of interested persons EMA recommends withdrawal of marketing authorisation for amfepramone medicines download document …
Important notification
31.05.2022 To the attention of manufacturers of medical devices and/or in vitro diagnostic medical devices in Romania and all interested […]
Important notification
11.05.2022 To the attention of interested persons The NAMMDR would like to inform you about the 9th Romanian Pharmacovigilance Workshop […]
Press release
06.05.2022 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2022 download […]
Press release
12.04.2022 To the attention of interested persons THE NAMMDR encourages the reporting of adverse effects of medicines for human use […]
Press release
08.04.2022 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4 – 7 April […]
Press release
07.03.2022 To the attention of interested persons ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines download […]
Press release
07.03.2022 To the attention of interested persons COVID-19: Joint statement from ECDC and EMA on the administration of a fourth […]